Delivery Order SPE2DB22D2005-SPE2DB24FJRE9

Award Date 8/12/24
Potential Completion Date 8/13/24
Potential Value $20K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of ADVAIR HFA 230-21 MCG INHALER 12GM, a respiratory medication, and has a ceiling value of $73,209.55. The contract is a firm fixed-price, delivery order contract with a period of performance through January 7, 2025. The contract was not set aside for any specific business type. AmerisourceBergen holds a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ADVAIR HFA 115-21 MCG INHALER 12GM, a pharmaceutical product, with a ceiling value of $2,757.91. The contract is a firm fixed price, non-set-aside, delivery order contract with a performance period ending on June 16, 2025. Amerisourcebergen Drug Corp holds a significant...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of ADVAIR HFA 230-21 MCG INHALER 12GM. The contract, with a ceiling value of $14,555.07, is a firm-fixed-price delivery order with an ultimate completion date of August 2, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999, for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ADVAIR HFA 230-21 MCG INHALER 12GM, a medical product, with a ceiling value of $3,152.10 and an ultimate completion date of April 9, 2025. The contract is a firm fixed-price delivery order and does not have a set-aside designation. AmerisourceBergen Drug Corp holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,837.87 firm fixed-price contract is for the supply of ADVAIR HFA 115-21 MCG INHALER 12GM, a prescription pharmaceutical product. The contract has an ultimate completion date of March 8, 2024. This delivery order is issued under a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,033.17, is for the delivery of an ADVAIR HFA 115-21 MCG INHALER 12GM medication. The contract has an ultimate completion date of May 22, 2024 and is a firm fixed-price delivery order. The contract is not associated with a set-aside designation. AmerisourceBergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distribution company. The contract is for the delivery of ADVAIR HFA 230-21 MCG INHALER 12GM, a respiratory medication. The contract has a total ceiling value of $2,988.34 and is set to expire on April 1, 2024. This contract is a firm fixed-price delivery order and is not designated as a set-aside. AmerisourceBergen Drug Corporation holds a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of an ADVAIR HFA 230-21 MCG INHALER 12GM product. The contract has a ceiling value of $2,194.71 and a completion date of September 19, 2024. It is a firm fixed-price contract, classified as a delivery order contract with no set-aside designation. Amerisourcebergen Drug Corp's Corporate Office division is the prime contractor for this...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of ADVAIR HFA 115-21 MCG INHALER 12GM. The contract has a ceiling value of $16,287.03 and an ultimate completion date of August 1, 2024. It is a firm-fixed-price contract with no set-aside designation. This contract represents a task order or delivery under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,759.09 firm fixed price contract is for the delivery of ADVAIR HFA 230-21 MCG INHALER 12GM, a prescription medication. The contract has an ultimate completion date of May 29, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
  • SPE2DB22D2005
    Indefinite Delivery Contract
  • SPE2DB22D2005-SPE2DB24FJRE9
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of ADVAIR HFA 230-21 MCG INHALER 12GM, a prescription medication. The contract has a ceiling value of $19,902.81 and an ultimate completion date of August 13, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract is a firm fixed-price type and does not have a set-aside designation.

Generated 11/11/24, 9:31 AM